Cyclic AMP synchronizes evoked quantal release at frog neuromuscular junctions.

At frog neuromuscular junction, noradrenaline (NA) shortens the release period for evoked quantal release acting on a beta1 receptor. To test the hypothesis that this action of NA is mediated by cAMP, we measured the latencies of focally recorded uni-quantal endplate currents (EPCs) after application of dibutyryl-cAMP (db-cAMP) and adenylyl cyclase activator, forskolin. The interval between the time when responses with minimal delay appeared and the point at which 90% of all latencies had occurred (P90 parameter) was shortened in the presence of both 1 x 10(-6) mol/l db-cAMP and 1 x 10(-6) mol/l forskolin by about 30%.

Noradrenaline synchronizes evoked quantal release at frog neuromuscular junctions.

1. Noradrenaline (NA) increases synaptic efficacy at the frog neuromuscular junction. To test the hypothesis that one of the actions of NA is to shorten the period over which evoked quanta are released, we measured the latencies of focally recorded uniquantal endplate currents (EPCs).